Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword?

Mostra el registre complet Registre parcial de l'ítem

• dc.contributor.author Muñoz Cánoves, Pura, 1962-ca
• dc.contributor.author Scheele, Camillaca
• dc.contributor.author Pedersen, Bente K.ca
• dc.contributor.author Serrano, Antonio L.ca
• dc.date.accessioned 2015-11-27T19:48:01Z
• dc.date.available 2015-11-27T19:48:01Z
• dc.date.issued 2013
• dc.description.abstract Interleukin (IL)-6 is a cytokine with pleiotropic functions in different tissues and organs. Skeletal muscle produces and releases significant levels of IL-6 after prolonged exercise and is therefore considered as a myokine. Muscle is also an important target of the cytokine. IL-6 signaling has been associated with stimulation of hypertrophic muscle growth and myogenesis through regulation of the proliferative capacity of muscle stem cells. Additional beneficial effects of IL-6 include regulation of energy metabolism, which is related to the capacity of actively contracting muscle to synthesize and release IL-6. Paradoxically, deleterious actions for IL-6 have also been proposed, such as promotion of atrophy and muscle wasting. We review the current evidence for these apparently contradictory effects, the mechanisms involved and discuss their possible biological implicationsca
• dc.description.sponsorship The authors acknowledge funding from EU-FP7 (Myoage) and MICINN (SAF2009-09782, FIS-PS09/01267, SAF2012-38547, PLE2009-0124, CIBERNED), AFM, Fundación Marató-TV3, MDA, EU-FP7 (Optistem and Endostem). The Centre of Inflammation and Metabolism (CIM) is supported by a grant from the Danish National Research Foundation (DNRF55).
• dc.format.mimetype application/pdfca
• dc.identifier.citation Muñoz-Cánoves P, Scheele C, Pedersen BK, Serrano AL. Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword?. FEBS journal. 2013;280(17):4131-48. DOI: 10.1111/febs.12338ca
• dc.identifier.doi http://dx.doi.org/10.1111/febs.12338
• dc.identifier.issn 1742-464X
• dc.identifier.uri http://hdl.handle.net/10230/25260
• dc.language.iso engca
• dc.publisher Wileyca
• dc.relation.ispartof FEBS journal. 2013;280(17):4131-48
• dc.relation.projectID info:eu-repo/grantAgreement/ES/3PN/SAF2012-38547
• dc.relation.projectID info:eu-repo/grantAgreement/ES/3PN/SAF2009-09782
• dc.relation.projectID info:eu-repo/grantAgreement/ES/3PN/PLE2009-0124
• dc.rights © The Authors. FEBS Journal published by John Wiley & Sons Ltd on behalf of FEBS. This is an open access article under the terms of the Creative Commons Attribution-Non Commercial-NoDerivs Licence, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.ca
• dc.rights.accessRights info:eu-repo/semantics/openAccessca
• dc.subject.keyword Growth/atrophy
• dc.subject.keyword IL-6
• dc.subject.keyword Inflammation
• dc.subject.keyword Metabolism
• dc.subject.keyword Myogenesis
• dc.subject.keyword Myokine
• dc.subject.keyword Regeneration
• dc.subject.keyword Satellite cell
• dc.subject.keyword Signaling
• dc.subject.keyword Pathway
• dc.subject.keyword Skeletal muscle
• dc.subject.other Músculs -- Creixementca
• dc.title Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword?ca
• dc.type info:eu-repo/semantics/articleca
• dc.type.version info:eu-repo/semantics/publishedVersionca